ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentSchlierenRepertoire Immune Medicines (Switzerland) AG
Repertoire Immune Medicines (Switzerland) AG Logo
Verified· 2 sources

Repertoire Immune Medicines (Switzerland) AG

Summary

About the company

The core activity of Repertoire Immune Medicines is the development of innovative immunotherapies for various therapeutic areas, particularly for cancer, autoimmune diseases, and infectious diseases. The company utilizes its proprietary DECODE platform to decipher the unique immune codes of the human body and develop medicines that can program the immune system to selectively eliminate tumors or restore balance to the immune system in autoimmune diseases.

AI-generated
Offering

Products & services

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Industry:
Research & Development
Pharmaceutical Industry
✓ Offered6
DECODE Platform
Suite of integrated experimental and computational technologies for analysing the immunological synapse system, identifying TCRs and disease-relevant epitopes across all human HLAs.
TCR-Bispecific Immune Medicines
Off-the-shelf TCR-bispecifics with a TCR, anti-CD3 module and a tumor-specific epitope; developed for solid and haematological cancers.
mRNA Cancer Vaccines
Off-the-shelf mRNA cancer vaccines with shared, highly immunogenic tumor-specific epitopes in lipid nanoparticles; under development for non-small cell lung cancer and colorectal cancer.
mRNA Tolerizing Vaccines
Off-the-shelf mRNA tolerizing vaccines with disease-relevant, tissue-specific epitopes and an immunomodulator; developed to restore immune homeostasis in autoimmune diseases.
Programmed immunotherapies for cancer
Targeted immune medicines for the treatment of solid and haematological tumours, including several programmed approaches for different cancer types.
Programmed immunotherapies for autoimmune diseases
Targeted immune medicines for the treatment of autoimmune diseases, aiming to specifically induce tolerance to disease-relevant immune responses and enable remission.
Comparisons

Repertoire Immune Medicines (Switzerland) AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Repertoire Immune Medicines (Switzerland) AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Repertoire Immune Medicines (Switzerland) AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 27
8952 Schlieren

At a glance

Legal form
Corporation
UID
CHE-153.467.041
Founded
2018 · 8 years
Last commercial register change
April 17, 2025
Employees
21 to 50

Knowledge

No knowledge articles yet

Once Repertoire Immune Medicines (Switzerland) AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

HA
hemotune AG
Schlieren
AT
Amicus Therapeutics Switzerland GmbH
Zurich
EA
evitria AG
Fahrweid
FN
Foundation National Institute for Cancer Epidemiology and Registration (NICER)
Zurich
LI
Ludwig Institut für Krebsforschung AG
Zurich
EA
EVIIVE AG
Obfelden
DA
Dr. Andres Pharma AG
Zurich
DF
Dr. Falk Pharma AG
Glattbrugg